
|Articles|August 15, 2003
NSAID helps reduce pain after cataract, refractive surgery
Duluth, GA-Diclofenac sodium ophthalmic solution (Voltaren, Novartis Ophthalmics) is a nonsteroidal anti-inflammatory drug (NSAID) with a proven track record. It is the drug of choice to relieve pain following cataract or refractive surgery, and it has maintained that position despite the increased incidence of corneal melt associated with a generic version of the drug, according to Douglas A. Katsev, MD. He described diclofenac as a staple in his private practice in Santa Barbara, CA.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
What if? Ophthalmology without OCT – Part 3
4
Cataract and refractive surgery: Trends, challenges, and innovations
5


















































.png)


